SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP. (2024). Mediterranean Journal of Hematology and Infectious Diseases, 16(1), e2024020. https://doi.org/10.4084/MJHID.2024.020